Martingale Asset Management’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,084
| Closed | -$192K | – | 888 |
|
|
2023
Q1 | $192K | Hold |
1,084
| – | – | ﹤0.01% | 784 |
|
|
2022
Q4 | $419K | Buy |
1,084
+759
| +234% | +$294K | 0.01% | 656 |
|
|
2022
Q3 | $110K | Sell |
325
-378
| -54% | -$128K | ﹤0.01% | 803 |
|
|
2022
Q2 | $232K | Sell |
703
-928
| -57% | -$306K | ﹤0.01% | 785 |
|
|
2022
Q1 | $714K | Buy |
1,631
+201
| +14% | +$88K | 0.01% | 562 |
|
|
2021
Q4 | $627K | Buy |
1,430
+70
| +5% | +$30.7K | 0.01% | 595 |
|
|
2021
Q3 | $757K | Buy |
1,360
+367
| +37% | +$204K | 0.01% | 577 |
|
|
2021
Q2 | $511K | Buy |
993
+675
| +212% | +$347K | 0.01% | 586 |
|
|
2021
Q1 | $249K | Buy |
+318
| New | +$249K | ﹤0.01% | 779 |
|